Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns

Frontiers in Immunology

Volumn 7, Issue AUG, 2016, Pages

  Abu Raya, Bahaa ^a   Smolen, Kinga K ^b   Willems, Fabienne ^b   Kollmann, Tobias R ^a   Marchant, Arnaud ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

HIV infection; HIV exposed uninfected; IgG; Inflammation; Newborn; Placenta; Pregnancy

Indexed keywords

BACTERIUM ANTIBODY; CYTOKINE; FC RECEPTOR; IMMUNE TRANSFER FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MATERNAL ANTIBODY; TUMOR NECROSIS FACTOR; VIRUS ANTIBODY; ZIDOVUDINE;

BREAST FEEDING; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFLAMMATION; INFLUENZA; MALARIA; MATERNAL ANTIMICROBIAL IMMUNITY; MEASLES; MRNA EXPRESSION ASSAY; NEWBORN; PASSIVE IMMUNIZATION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; REVIEW; STREPTOCOCCUS INFECTION; TETANUS; VIRUS IMMUNITY;

EID: 84989361144     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00338     Document Type: Review

References (84)

1. World Health Report. Make Every Mother and Child Count. Geneva: WHO (2005)
2. Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? where? why? Lancet (2005) 365(9642):891-900. doi:10.1016/S0140-6736(05)71048-5
3. Ghazal P, Dickinson P, Smith CL. Early life response to infection. Curr Opin Infect Dis (2013) 26(3):213-8. doi:10.1097/QCO.0b013e32835fb8bf
4. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 37(5):771-83. doi:10.1016/j.immuni.2012.10.014
5. Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol (2014) 5:446. doi:10.3389/fimmu.2014.00446
6. Turfkruyer M, Verhasselt V. Breast milk and its impact on maturation of the neonatal immune system. Curr Opin Infect Dis (2015) 28(3):199-206. doi:10.1097/QCO.0000000000000165
7. Abu Raya B, Srugo I, Kessel A, Peterman M, Bader D, Peri R, et al. The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination. Vaccine (2014) 32(43):5632-7. doi:10.1016/j.vaccine.2014.08.006
8. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis (2012) 12(4):330-40. doi:10.1016/S1473-3099(11)70341-3
9. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol (2009) 9(4):235-45. doi:10.1038/nri2524
10. Moir S, Fauci AS. B-cell exhaustion in HIV infection: the role of immune activation. Curr Opin HIV AIDS (2014) 9(5):472-7. doi:10.1097/COH.0000000000000092
11. Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, O'Shea MA, et al. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis (2008) 197(4):572-9. doi:10.1086/526789
12. Ruffin N, Thang PH, Rethi B, Nilsson A, Chiodi F. The impact of inflammation and immune activation on B cell differentiation during HIV-1 infection. Front Immunol (2012) 2:90. doi:10.3389/fimmu.2011.00090
13. Truong HM, Sim MS, Dillon M, Uittenbogaart CH, Dickover R, Plaeger SF, et al. Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers. Clin Vaccine Immunol (2010) 17(12):2024-8. doi:10.1128/CVI.00088-10
14. Slogrove AL, Goetghebuer T, Cotton MF, Singer J, Bettinger JA. Pattern of infectious morbidity in HIV-exposed uninfected infants and children. Front Immunol (2016) 7:164. doi:10.3389/fimmu.2016.00164
15. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics (2010) 126(3):e631-8. doi:10.1542/peds.2010-0183
16. Adler C, Haelterman E, Barlow P, Marchant A, Levy J, Goetghebuer T. Severe infections in HIV-exposed uninfected infants born in a European country. PLoS One (2015) 10(8):e0135375. doi:10.1371/journal.pone.0135375
17. Mussi-Pinhata MM, Motta F, Freimanis-Hance L, de Souza R, Szyld E, Succi RC, et al. Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis (2010) 14(Suppl 3):e176-82. doi:10.1016/j.ijid.2010.01.006
18. Pavlinac PB, John-Stewart GC, Naulikha JM, Onchiri FM, Denno DM, Odundo EA, et al. High-risk enteric pathogens associated with HIV infection and HIV exposure in Kenyan children with acute diarrhoea. AIDS (2014) 28(15):2287-96. doi:10.1097/QAD.0000000000000396
19. Firan M, Bawdon R, Radu C, Ober RJ, Eaken D, Antohe F, et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol (2001) 13(8):993-1002. doi:10.1093/intimm/13.8.993
20. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol (1996) 36(5):248-55. doi:10.1111/j.1600-0897.1996.tb00172.x
21. Abu Raya B, Srugo I, Kessel A, Peterman M, Bader D, Gonen R, et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels-a prospective study. Vaccine (2014) 32(44):5787-93. doi:10.1016/j.vaccine.2014.08.038
22. Lin FY, Weisman LE, Azimi PH, Philips JB, Clark P, Regan J, et al. Level of maternal IgG anti-group B Streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis (2004) 190(5):928-34. doi:10.1086/422756
23. Baker CJ, Carey VJ, Rench MA, Edwards MS, Hillier SL, Kasper DL, et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis (2014) 209(5):781-8. doi:10.1093/infdis/jit549
24. Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD. Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol (1994) 1(6):667-9
25. Sarmay G. Functional studies on Fc receptors. Immunol Today (1992) 13(8):A6-9. doi:10.1016/0167-5699(92)90056-D
26. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 5:520. doi:10.3389/fimmu.2014.00520
27. de Moraes-Pinto MI, Farhat CK, Carbonare SB, Curti SP, Otsubo ME, Lazarotti DS, et al. Maternally acquired immunity in newborns from women infected by the human immunodeficiency virus. Acta Paediatr (1993) 82(12):1034-8
28. de Moraes-Pinto MI, Almeida AC, Kenj G, Filgueiras TE, Tobias W, Santos AM, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis (1996) 173(5):1077-84. doi:10.1093/infdis/173.5.1077
29. Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis (2007) 196(4):550-7. doi:10.1086/519845
30. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol (2012) 2012:985646. doi:10.1155/2012/985646
31. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA (2011) 305(6):576-84. doi:10.1001/jama.2011.100
32. Baroncelli S, Galluzzo CM, Mancinelli S, Andreotti M, Jere H, Amici R, et al. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children. Infect Dis (2016) 48(4):317-21. doi:10.3109/23744235.2015.1115895
33. Gupta A, Mathad JS, Yang WT, Singh HK, Gupte N, Mave V, et al. Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs. Vaccine (2014) 32(13):1466-72. doi:10.1016/j.vaccine.2014.01.033
34. Jones C, Pollock L, Barnett SM, Battersby A, Kampmann B. Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. BMJ Open (2013) 3(4):e002473. doi:10.1136/bmjopen-2012-002473
35. de Moraes-Pinto MI, Verhoeff F, Chimsuku L, Milligan PJ, Wesumperuma L, Broadhead RL, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed (1998) 79(3):F202-5. doi:10.1136/fn.79.3.F202
36. Almeida Vde C, Mussi-Pinhata MM, De Souza CB, Kubo CA, Martinez EZ, Carneiro-Sampaio MM, et al. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants. Vaccine (2009) 27(29):3856-61. doi:10.1016/j.vaccine.2009.04.018
37. Baroncelli S, Galluzzo CM, Liotta G, Andreotti M, Jere H, Erba F, et al. Anti-Streptococcus pneumoniae and rotavirus IgG levels in HIV-positive women do not correlate with maternal status and infant morbidity and mortality. J Med Microbiol (2015) 64(7):795-7. doi:10.1099/jmm.0.000087
38. Gaensbauer JT, Rakhola JT, Onyango-Makumbi C, Mubiru M, Westcott JE, Krebs NF, et al. Impaired Haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but-uninfected infants. Clin Vaccine Immunol (2014) 21(12):1661-7. doi:10.1128/CVI.00356-14
39. Le Doare K, Allen L, Kampmann B, Heath PT, Taylor S, Hesseling AC, et al. Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection. Vaccine (2015) 33(5):621-7. doi:10.1016/j.vaccine.2014.12.025
40. Dangor Z, Kwatra G, Izu A, Adrian P, van Niekerk N, Cutland CL, et al. HIV-1 is associated with lower group B Streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis (2015) 212(3):453-62. doi:10.1093/infdis/jiv064
41. Heyderman RS, Madhi SA, French N, Cutland C, Ngwira B, Kayambo D, et al. Group B Streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis (2016) 16:546-55. doi:10.1016/S1473-3099(15)00484-3
42. Ayisi JG, Branch OH, Rafi-Janajreh A, van Eijk AM, ter Kuile FO, Rosen DH, et al. Does infection with human immunodeficiency virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect (2003) 46(3):164-72. doi:10.1053/jinf.2002.1088
43. Ned RM, Price AE, Crawford SB, Ayisi JG, van Eijk AM, Otieno JA, et al. Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infants. J Infect Dis (2008) 198(11):1609-19. doi:10.1086/593066
44. Bashir MF, Elechi HA, Ashir MG, Rabasa AI, Bukbuk DN, Usman AB, et al. Neonatal tetanus immunity in Nigeria: the effect of HIV infection on serum levels and transplacental transfer of antibodies. J Trop Med (2016) 2016:7439605. doi:10.1155/2016/7439605
45. Thwaites CL, Loan HT. Eradication of tetanus. Br Med Bull (2015) 116:69-77. doi:10.1093/bmb/ldv044
46. Scott S, Cumberland P, Shulman CE, Cousens S, Cohen BJ, Brown DW, et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis (2005) 191(11):1854-60. doi:10.1086/429963
47. Farquhar C, Nduati R, Haigwood N, Sutton W, Mbori-Ngacha D, Richardson B, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr (2005) 40(4):494-7. doi:10.1097/01.qai.0000168179.68781.95
48. Moro L, Bardají A, Nhampossa T, Mandomando I, Serra-Casas E, Sigaúque B, et al. Malaria and HIV infection in Mozambican pregnant women are associated with reduced transfer of antimalarial antibodies to their newborns. J Infect Dis (2015) 211(6):1004-14. doi:10.1093/infdis/jiu547
49. Farouk S, Navér L, Smedman L. Impaired neutralizing activity by transplacental measles antibodies in infants born to HIV-1-infected mothers. Acta Paediatr (2012) 101(11):e500-4. doi:10.1111/j.1651-2227.2012.02793.x
50. Kemp MW. Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol (2014) 5:574. doi:10.3389/fimmu.2014.00574
51. López M, Figueras F, Coll O, Goncé A, Hernández S, Loncá M, et al. Inflammatory markers related to microbial translocation among HIV-infected pregnant women: a risk factor of preterm delivery. J Infect Dis (2016) 213(3):343-50. doi:10.1093/infdis/jiv416
52. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol (1998) 179(1):194-202. doi:10.1016/S0002-9378(98)70272-8
53. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol (1997) 177(2):406-11. doi:10.1016/S0002-9378(97)70206-0
54. Mandal M, Donnelly R, Elkabes S, Zhang P, Davini D, David BT, et al. Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring. Brain Behav Immun (2013) 33:33-45. doi:10.1016/j.bbi.2013.04.012
55. Kerr SJ, Puthanakit T, Vibol U, Aurpibul L, Vonthanak S, Kosalaraksa P, et al. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care (2014) 26(11):1327-35. doi:10.1080/09540121.2014.920949
56. Kapetanovic S, Griner R, Zeldow B, Nichols S, Leister E, Gelbard HA, et al. Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis. AIDS (2014) 28(3):355-64. doi:10.1097/QAD.0000000000000072
57. Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis (2016) 16(6):e92-107. doi:10.1016/S1473-3099(16)00055-4
58. Mikyas Y, Aziz N, Harawa N, Gorre M, Neagos N, Nogueira M, et al. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol (1997) 33(2):157-70. doi:10.1016/S0165-0378(97)00018-1
59. Sachdeva N, Oshima K, Cotter A, Ashman M, Davila L, Okazaki T, et al. Analysis of immunological markers associated with pregnancy and HIV-1 infection: relevance in perinatal transmission in HIV-1-infected pregnant women with low plasma viral load. Am J Reprod Immunol (2008) 60(3):264-73. doi:10.1111/j.1600-0897.2008.00627.x
60. Borges-Almeida E, Milanez HM, Vilela MM, Cunha FG, Abramczuk BM, Reis-Alves SC, et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect Dis (2011) 11:38. doi:10.1186/1471-2334-11-38
61. Zaretsky MV, Alexander JM, Byrd W, Bawdon RE. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol (2004) 103(3):546-50. doi:10.1097/01.AOG.0000114980.40445.83
62. Aaltonen R, Heikkinen T, Hakala K, Laine K, Alanen A. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol (2005) 106(4):802-7. doi:10.1097/01.AOG.0000178750.84837.ed
63. Reuben JM, Turpin JA, Lee BN, Doyle M, Gonik B, Jacobson R, et al. Induction of inflammatory cytokines in placental monocytes of gravidae infected with the human immunodeficiency virus type 1. J Interferon Cytokine Res (1996) 16(11):963-71. doi:10.1089/jir.1996.16.963
64. Lee BN, Ordonez N, Popek EJ, Lu JG, Helfgott A, Eriksen N, et al. Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol (1997) 71(5):3628-35
65. Lee BN, Hammill H, Popek EJ, Cron S, Kozinetz C, Paul M, et al. Production of interferons and beta-chemokines by placental trophoblasts of HIV-1-infected women. Infect Dis Obstet Gynecol (2001) 9(2):95-104. doi:10.1155/S1064744901000175
66. Schramm DB, Kuhn L, Gray GE, Tiemessen CT. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr (2006) 42(5):545-53. doi:10.1097/01.qai.0000225009.30698.ce
67. Bunders MJ, van Hamme JL, Jansen MH, Boer K, Kootstra NA, Kuijpers TW. Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1. Sci Rep (2014) 4:6690. doi:10.1038/srep06690
68. Reikie BA, Adams RC, Leligdowicz A, Ho K, Naidoo S, Ruck CE, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr (2014) 66(3):245-55. doi:10.1097/QAI.0000000000000161
69. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol (2008) 126(3):243-50. doi:10.1016/j.clim.2007.11.004
70. Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, et al. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis (2000) 181(5):1590-7. doi:10.1086/315458
71. Van de Perre P, Simonon A, Hitimana DG, Dabis F, Msellati P, Mukamabano B, et al. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 341(8850):914-8. doi:10.1016/0140-6736(93)91210-D
72. Duprat C, Mohammed Z, Datta P, Stackiw W, Ndinya-Achola JO, Kreiss JK, et al. Human immunodeficiency virus type 1 IgA antibody in breast milk and serum. Pediatr Infect Dis J (1994) 13(7):603-8. doi:10.1097/00006454-199407000-00004
73. Becquart P, Hocini H, Lévy M, Sépou A, Kazatchkine MD, Bélec L. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis (2000) 181(2):532-9. doi:10.1086/315255
74. Kuhn L, Trabattoni D, Kankasa C, Sinkala M, Lissoni F, Ghosh M, et al. HIV-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Pediatr (2006) 149(5):611-6. doi:10.1016/j.jpeds.2006.06.017
75. Shapiro RL, Lockman S, Kim S, Smeaton L, Rahkola JT, Thior I, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis (2007) 196(4):562-9. doi:10.1086/519847
76. Abzug MJ, Nachman SA, Muresan P, Handelsman E, Watts DH, Fenton T, et al. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women. Clin Infect Dis (2013) 56(10):1488-97. doi:10.1093/cid/cit057
77. Weinberg A, Muresan P, Richardson KM, Fenton T, Dominguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS One (2015) 10(4):e0122431. doi:10.1371/journal.pone.0122431
78. Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 371(10):918-31. doi:10.1056/NEJMoa1401480
79. Nunes MC, Cutland CL, Dighero B, Bate J, Jones S, Hugo A, et al. Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants. J Infect Dis (2015) 212(12):1976-87. doi:10.1093/infdis/jiv339
80. Richardson K, Weinberg A. Reduced immunogenicity of influenza vaccines in HIV-infected compared with uninfected pregnant women is associated with regulatory T cells. AIDS (2011) 25(5):595-602. doi:10.1097/QAD.0b013e32834411a8
81. Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet (2015) 385(9965):362-70. doi:10.1016/S0140-6736(14)60236-1
82. Faye A, Pornprasert S, Mary JY, Dolcini G, Derrien M, Barré-Sinoussi F, et al. Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol (2007) 149(3):430-9. doi:10.1111/j.1365-2249.2007.03411.x
83. Pornprasert S, Faye A, Mary JY, Dolcini G, Leechanachai P, Chaouat G, et al. Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta (2006) 27(9-10):989-95. doi:10.1016/j.placenta.2005.10.010
84. Kasahara TM, Hygino J, Blanco B, Xavier L, Araújo-Lima CF, Guillermo LV, et al. The impact of maternal anti-retroviral therapy on cytokine profile in the uninfected neonates. Hum Immunol (2013) 74(9):1051-6. doi:10.1016/j.humimm.2013.06.010